Petra Ott
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Diabetes Treatment and Management 4
- Diabetes Management and Research 1
-
- Medical Practices and Rehabilitation 1
- Co-authors
- Markolf Hanefeld E (5 shared papers)Carsta Koehler (2 shared papers)Silvina Gallo (1 shared paper)
- Journals
- The Lancet (2 papers)Cardiovascular Diabetology (1 paper)Hormone and Metabolic Research (1 paper)Diabetologia (1 paper)DMW - Deutsche Medizinische Wochenschrift (1 paper)
- Partner nations
- Germany
In The Last Decade
Petra Ott
8 papers receiving 2.9k citations
Petra Ott's Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 2.2k
- Nephrology 415
- Cardiology and Cardiovascular Medicine 295
- Transplantation 20
- Pharmacology 79
Countries citing papers authored by Petra Ott
This map shows the geographic impact of Petra Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Ott more than expected).
Fields of papers citing papers by Petra Ott
This network shows the impact of papers produced by Petra Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Ott. The network helps show where Petra Ott may publish in the future.
Co-authors
The 3 scholars most cited alongside Petra Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2345 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 498 |
| 3 | 2007 | 67 | |
| 4 | 2004 | 48 | |
| 5 | 2007 | 40 | |
| 6 | 2009 | 16 | |
| 7 | 2006 | 4 | |
| 8 | 2002 | 1 | |
| 9 | 2006 | 1 |
About Petra Ott
Petra Ott is a scholar working on Endocrinology, Diabetes and Metabolism, Physical Therapy, Sports Therapy and Rehabilitation, Nephrology, Physiology and Epidemiology, having authored 9 papers that have together received 3k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Diabetes Treatment and Management (4 papers), Chronic Kidney Disease and Diabetes (1 paper), Medical Practices and Rehabilitation (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Adipose Tissue and Metabolism (1 paper) and Diabetes Management and Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Nephrology (415 citations), Cardiology and Cardiovascular Medicine (295 citations), Transplantation (20 citations) and Pharmacology (79 citations). Petra Ott has collaborated with scholars based in Germany. Frequent co-authors include Markolf Hanefeld E, Carsta Koehler and Silvina Gallo. Their work appears in journals such as The Lancet, Cardiovascular Diabetology, Hormone and Metabolic Research, Diabetologia and DMW - Deutsche Medizinische Wochenschrift.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.